Technavio Announces the Publication of its Research Report Global Blood Stream Infection Testing Market 2016-2020
Technavio recognizes the following companies as the key players in the global blood stream infection testing market: BD, bioMérieux, Cepheid, Roche Diagnostics, and Thermo Fisher.
Other prominent vendors in the market are: IRIDICA, Alere, Beckman Coulter, Bruker, Nanosphere, Siemens, Dade Behring, AdvanDX, Eurogentec, and AB Sciex.
Browse full report with TOC @ https://marketreportscenter.com/reports/470021/global-blood-stream-infection-testing-market-2016-2020
Commenting on the report, an analyst from Technavios team said: One of latest trends in the market is focus on early diagnosis. Blood stream infection is associated with high mortality rates. If blood stream infection has not been diagnosed in the early stage, it continues to be severe and becomes life-threatening. Sepsis is one of the major blood stream infections that leads to death in new-born and children. Early detection of sepsis allows physicians to initiate the appropriate antimicrobial therapy that leads to positive treatment outcomes. Pediatric patients with severe burns, trauma, immunodeficiency, prematurity and malignancy have increased the chances of sepsis with fatality rate of 10-50% worldwide. In addition, the prolonged hospitals stay and supportive pediatric care also increase the total healthcare budget for patients. Early diagnosis and rapid detection of the blood stream infections leads to proper treatment that reduce the antibiotic resistance rates. A rapid diagnostic test SeptiFast is used to detect sepsis within very short period of time (6 hours faster than conventional blood culture tests). Physicians are opting this rapid test to diagnose the state of sepsis in individuals so as to avoid the unnecessary health complications. The initiative of early diagnosis of blood stream infection will increase the adoption rate of the blood stream infection testing products which lead to fuel the market growth.
According to the report, one of the primary drivers in the market is growing awareness of blood donation increasing the demand for BSI testing market. In recent times, the demand for blood and blood safety products is on the rise worldwide. The adoption of sophisticated surgical procedures is on high demand in hospitals due to advances in healthcare systems and improved medical coverage. The complex surgeries which need blood from donors are readily available. Some recent research studies estimated that the blood donations from voluntary blood donation campaigns and unpaid donors is going to increase by 5% during the forecast period in developing and developed countries. In the last decade, 73 countries together accounted for 90% of the overall blood donations. Annually, about 92 million people worldwide donate blood. WHO estimated that 108 million people worldwide donated blood in 2012, with high-income countries such as the US, the UK, Japan, France, and Germany accounting for 50% of the overall blood donations. Low-income countries including Bangladesh and Egypt also reported a surge in blood donations. Blood collection in Vietnam increased from 0.26 million donors in 2002 to 0.77 million donors in 2012. The rise in blood donations increases the need for blood culture devices. These devices screen the collected blood for any diseases-causing agents or other microbial contamination.
Further, the report states that one major challenge in the market is high cost of instruments restricts market growth. The automated blood culture test instruments or equipment are usually expensive. The real time PCR instruments are more expensive among other instruments. The real-time PCR of the BioRad is around $9,900 and Applied Biosystems provide real-time PCR for around $14,500. In developing countries, the blood culture test market is highly impacted by expensive instruments than developed countries due to less affordability among people. Though instruments are one-time investment, the high cost of these instruments prevent hospital authorities to purchase them.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/470021
About Blood Stream Infection Testing
The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting.
Technavios analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top four vendors operating in the market.
The market is divided into the following segments based on geography:
Technavio’s report, Global Blood Stream Infection Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/470021
Connect for more details:
Market Reports Center